NASDAQ: RPRX
Royalty Pharma PLC Stock Ownership - Who owns Royalty Pharma?

Insider buying vs selling

Have Royalty Pharma PLC insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Terrance P. CoyneEVP CFO2025-11-2410,686$37.96
$405.64kSell
Terrance P. CoyneEVP CFO2025-11-2455,146$38.67
$2.13MSell
Terrance P. CoyneEVP CFO2025-11-24624$37.96
$23.69kSell
Terrance P. CoyneEVP CFO2025-11-243,126$38.67
$120.88kSell
George W. LloydEVP Investments CLO2025-11-1925,530$38.28
$977.26kSell
George W. LloydEVP Investments CLO2025-11-192,770$38.29
$106.05kSell
George W. LloydEVP Investments CLO2025-11-19230$39.03
$8.98kSell
George W. LloydEVP Investments CLO2025-11-1947,798$38.28
$1.83MSell
George W. LloydEVP Investments CLO2025-11-194,628$39.01
$180.53kSell
George W. LloydEVP Investments CLO2025-11-1947,401$38.28
$1.81MSell

1 of 3

RPRX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when RPRX insiders and whales buy or sell their stock.

RPRX Shareholders

What type of owners hold Royalty Pharma PLC stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Morgan Stanley7.65%44,163,954$1.76BInstitution
Adage Capital Partners GP LLC6.71%38,714,280$1.54BInsider
Fmr LLC4.85%27,986,714$1.11BInstitution
Capital International Investors4.71%27,212,694$1.08BInstitution
Blackrock Inc4.54%26,200,503$1.04BInstitution
1978 Sicaf Sif Sa 1. Gg3.83%22,081,156$879.71MInsider
1978 Sicaf Sif Sa Gg3.71%21,426,170$853.62MInsider
Baillie Gifford Co3.01%17,372,502$692.12MInstitution
Swedbank Ab2.11%12,200,270$486.06MInstitution
Adage Capital Partners GP LLC2.07%11,965,633$476.71MInstitution

1 of 3

RPRX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
RPRX56.74%17.41%Net SellingNet Selling
BNTX20.90%0.00%
UTHR86.69%13.31%Net SellingNet Selling
GMAB95.96%0.00%
INCY77.65%22.35%Net SellingNet Selling

Royalty Pharma Stock Ownership FAQ

Who owns Royalty Pharma?

Royalty Pharma (NASDAQ: RPRX) is owned by 56.74% institutional shareholders, 17.41% Royalty Pharma insiders, and 25.84% retail investors. Adage Capital Partners GP LLC is the largest individual Royalty Pharma shareholder, owning 38.71M shares representing 6.71% of the company. Adage Capital Partners GP LLC's Royalty Pharma shares are currently valued at $1.55B.

If you're new to stock investing, here's how to buy Royalty Pharma stock.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.